New combination therapies for asthma

Current Opinion in Pulmonary Medicine

Volumn 7, Issue 2, 2001, Pages 62-68

  Donohue, James F ^a,c   Ohar, Jill A ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE PROPIONATE; FORMOTEROL; INDOMETACIN; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MACROLIDE; MONTELUKAST; PRANLUKAST; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; THEOPHYLLINE; TRIAMCINOLONE; ZAFIRLUKAST; ZILEUTON;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DISEASE EXACERBATION; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; META ANALYSIS; PATHOPHYSIOLOGY; RESPIRATORY TRACT INFECTION; REVIEW; SMOOTH MUSCLE;

EID: 0035062954     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200103000-00002     Document Type: Review

References (50)

1. How often is prescribed medication taken as prescribed?
2. The effect of prescribed daily dose frequency on patient medication compliance
3. Classification of the effectiveness of combination treatments
4. 2-adrenergic receptor function in human nasal mucosa
5. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
6. Salmeterol facilitation of fluticasone-induced apoptosis in eosinophils of asthmatics pre- and post-antigen challenge
7. Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation
8. 2-agonists and corticosteroids on tumor necrosis factor-α-induced interleukin-8 release from cultured human airway smooth muscle cells
9. Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro
10. 2 agonist, assessed on airway biopsies and bronchoalveolar lavage in asthma
11. Bronchial biopsy in asthmatics treated with low and high-dose fluticasone propionate (FP) compared to low-dose FP combined with salmeterol
12. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma
13. Asthma survey demonstrates that the goals of the NHLBI have not been accomplished
14. The addition of salmeterol to fluticasone propianate versus increasing the dose of fluticasone propionate in patients with persistent asthma
15. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma
16. Inhaled fluticasone propionate and salmeterol in moderate adult asthma II: Exacerbations
17. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases
18. Addition of salmeterol versus doubling the dose of fluticasone propionate in patiens with mild to moderate asthma
19. Inhaled salmeterol and fluticasone: A study comparing monotherapy and combination therapy in asthma
20. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)
21. Effect of inhaled formoterol and budesonide on exacerbations of asthma
22. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trail
23. Combined salmeterol 50 μg and fluticasone propionate 250 μg in the Diskus device for the treatment of asthma
24. Salmeterol/fluticasone propionate (50/500 μg) in combination in a Diskus inhaler (Seretide) in effective and safe in the treatment of steroid-dependent asthma
25. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma
26. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: A randomized, controlled trial
27. A randomized controlled trial comparing zileuton with theophylline in moderate asthma
28. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multi-center trial
29. Montelukast, a once-daily leukotriene receptor antagonist in the treatment of chronic asthma: A multicenter, randomized, double-blind trial
30. Effects of 2 weeks of treatment with Fluticasone propionate 100 μg b.i.d. by comparison with zafirlukast 20 mg b.i.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma
31. Benefits from adding the 5 lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics
32. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids
33. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid
34. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma
35. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids
36. Lipid mediator pathways in the lung: Leukotrienes as a new target for the treatment of asthma
37. Combined antagonism of leukotrienes and histamine-produced predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics
38. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial
39. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled cortcosteroid plus montelukast
40. Montelukast added to inhaled beclomethasone in treatment of asthma
41. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: Design and rationale of a randomized, double-blind comparative study: The IMPAC investigation of montelukast as a partner agent for complementary therapy-trial
42. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics
43. Randomised, placebo controlled trail of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
44. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma
45. A comparison of low-dose inhaled budesonide plus theophylline and high dose inhaled budesonide for moderate asthma
46. Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice
47. Protocol therapy for acute asthma: Therapeutic benefit and cost savings
48. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: A metaanalysis of randomized clinical trials
49. (S)-Albuterol increased intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle
50. Effect of inhaled indomethacin in asthmatic patients taking high doses of inhaled corticosteroids